Content area
Full Text
After engineering Aravive’s reverse merger with the moribund Versartis, Ray Tabibiazar, M.D., is moving on to Twist Bioscience, where he will serve as senior vice president of corporate development and business strategy. He will also head up Twist’s biologics drug discovery unit, at least in the interim, as its acting general manager.
“Ray has been working with us as an adviser for two years, and we are thrilled to have him join us full time as we expand our focus on biologics drug discovery,” said Twist CEO Emily M. Leproust, Ph.D., in a statement. “In addition to his...